Skip to content

Clinical trials

Phase 3 Cystic Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 3 Country / region: United States Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20055
20064
20075
20086
20096
20107
20113
20123
20138
20144
201510
20164
20176
201810
20193
20203
20212
20223
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85
Terminated7
Active, not recruiting3
Withdrawn1
Recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated48
Gilead Sciences9
Anthera Pharmaceuticals5
Forest Laboratories5
PTC Therapeutics5
Solvay Pharmaceuticals3
Amgen2
Emory University2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Syntara2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis99
Exocrine Pancreatic Insufficiency15
Pseudomonas Infections7
Diabetes Mellitus4
Steatorrhea4
Lung Diseases3
Fibrosis2
Genetic Diseases, Inborn2
Infant, Newborn, Diseases2
Inflammation2

Trials

Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.